Pancreatic Cancer Research

ResearcherJapan Society for the Promotion of ScienceActive in the last 2 years

Katsuhisa Hirano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5270-7003; OpenAlex author ID A5072087361, A5158605704. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 8 papers · 2026: 1 paper

Papers 10

  1. Predictive Factors for Occult Metastases in Clinically M0 Pancreatic Cancer: A Prospective Multicenter Analysis of Staging Laparoscopy. Co-author DOI 10.1245/s10434-026-20728-8↗
  2. Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter… Co-author DOI 10.1002/ags3.70001↗
  3. Successful conversion surgery for patients with pancreatic cancer, positive peritoneal cytology, and liver metastasis who were treated with chemotherapy involv… Co-author DOI 10.1007/s12328-025-02175-2↗
  4. Risk Factors for Early Liver Recurrence After Pancreatic Cancer Resection. Co-author DOI 10.1097/mpa.0000000000002441↗
  5. A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Tri… Co-author DOI 10.1371/journal.pone.0325667↗
  6. Gastrojejunostomy for Asymptomatic Gastric Outlet Obstruction in Pancreatic Cancer May Contribute to Early Recovery. Co-author DOI 10.21873/anticanres.17618↗
  7. Novel CTC Detection Method in Patients with Pancreatic Cancer Using High-Resolution Image Scanning. Co-author DOI 10.3390/cancers17223640↗
  8. McKeown Esophagectomy for Esophageal Cancer Following Pancreaticoduodenectomy Using a Mesenteric Approach for Pancreatic Cancer: A Case Report. Co-author DOI 10.70352/scrj.cr.25-0204↗
  9. [Conversion Surgery for Pancreatic Cancer]. Co-author PMID 39957218↗
  10. Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer. Co-author DOI 10.3390/cancers13010036↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nana Kimura · 9 shared papers, 2020–2026 · strength 1.90
  2. Tsutomu Fujii · 9 shared papers, 2020–2025 · strength 1.83
  3. Mina Fukasawa · 6 shared papers, 2025 · strength 1.35
  4. Yoshihiro Shirai · 4 shared papers, 2025 · strength 0.93
  5. Takeshi Miwa · 3 shared papers, 2020–2025 · strength 0.49
  6. Takamichi Igarashi · 2 shared papers, 2025–2026 · strength 0.48
  7. Ayaka Itoh · 2 shared papers, 2025 · strength 0.48
  8. Masamichi Mizuma · 2 shared papers, 2025–2026 · strength 0.40
  9. Michiaki Unno · 2 shared papers, 2025–2026 · strength 0.40
  10. Fuyuhiko Motoi · 2 shared papers, 2025–2026 · strength 0.40
  11. Sohei Satoi · 2 shared papers, 2025 · strength 0.40
  12. Yasuhiro Kodera · 2 shared papers, 2020–2025 · strength 0.25
  13. Haruyoshi Tanaka · 1 shared paper, 2025 · strength 0.25
  14. Shimpei Maeda · 1 shared paper, 2026 · strength 0.23
  15. Masahiro Iseki · 1 shared paper, 2026 · strength 0.23
  16. Kyohei Ariake · 1 shared paper, 2026 · strength 0.23
  17. Shuichi Aoki · 1 shared paper, 2026 · strength 0.23
  18. Hiroaki Nagano · 1 shared paper, 2025 · strength 0.23
  19. Yoshifumi Takeyama · 1 shared paper, 2025 · strength 0.23
  20. Junji Furuse · 1 shared paper, 2025 · strength 0.23
  21. Makoto Ueno · 1 shared paper, 2025 · strength 0.23
  22. Mariko Horikawa · 1 shared paper, 2025 · strength 0.21
  23. Takahiro Manabe · 1 shared paper, 2025 · strength 0.18
  24. Yosuke Inoue · 1 shared paper, 2025 · strength 0.17
  25. So Yamaki · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.